Wednesday, September 28, 2016

Intra-Cellular Therapies Shares Plunge After Disappointing Drug Trial Results

Intra-Cellular Therapies said its lead drug candidate had a similar rate of effectiveness to placebo in a Phase 3 schizophrenia trial.

from WSJ.com: US Business http://ift.tt/2cWIzvC
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)